
Angiogenesis is the formation of blood vessels off of existing vessels, and is a key process in development and tumorigenesis. VEGF (vascular endothelial growth factor) is a potent activator of angiogenesis, and Notch is a protein that converts endothelial cells into tip and stalk cells, which are cell types required for vessel formation. A research group found that function-blocking antibodies for VEGFR-3, a VEGF receptor protein, caused a decrease in angiogenesis in developing mice and in tumors. However, this same research group more recently found that complete deletion of the VEGFR-3 gene caused excessive branching and sprouting during angiogenesis, as well as decreased Notch signaling. By finding varying results with similar, but subtly different approaches, Tammela and colleagues were able to distinguish bimodal functions of VEGFR-3 during angiogenesis. In the images above, blood vessels lacking the gene for VEGFR-3 (left) have more branching than wild-type vessels (right). Vessels lacking VEGFR-3 also have more filopodia (yellow dots, bottom row), actin-rich protrusions used by tip cells to guide branching.
Adapted by permission from Macmillan Publishers Ltd, copyright ©2011
No comments:
Post a Comment